Maternal pertussis vaccination boosts infant protection up to eight months

In a large-scale Australian study, maternal vaccination during pregnancy significantly increased pertussis resistance in infants up to eight months. While it slightly reduced the effectiveness of infants’ routine vaccinations, it did not increase infection risk.

Data Insights – Pharmaceutical Technology

By Company Name No Filter Selected Bristol-Myers Squibb (346) Merck (243) Novartis (232) AstraZeneca (220) Pfizer (217) F. Hoffmann-La Roche (169) AbbVie (150) BeiGene (144)

March 14, 2024

Research suggests flexible approach to antiplatelet management after drug-eluting stent implantation

Among patients undergoing non-cardiac surgery more than 1 year after coronary drug-eluting stent (DES) implantation, there was no difference with respect to ischaemic outcomes or

September 1, 2024

Illumina to divest Grail, two years after $8B deal was stymied by antitrust issues

Illumina will divest its cancer diagnostic subsidiary Grail, it announced Sunday, ending a painful years-long saga in which the prized acquisition was held up by

December 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.